Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
While your body makes its own glutathione, factors like aging, stress, poor diet, and environmental toxins can deplete your levels
Early-phase clinical trial data, including results from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), demonstrated significant weight reduction in adults with obesity (without type 2 diabetes), with participants receiving the highest dose losing a mean of approximately 24% of their body weight over 48 weeks
Where appetite circuitry is examined, immediate-early gene markers and neuropeptide expression in hypothalamic nuclei can complement behavioral readouts
Phase 2 trial in type 2 diabetes (Lancet 2023) also showed superior weight loss for the combination versus either monotherapy
KLOW builds on the GLOW formula by adding a fourth peptide KPV creating an 80mg quad-peptide blend with enhanced anti-inflammatory and gut-protective properties
